Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 262 clinical trials
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of …

hysterectomy
ak002
dysphagia
eosinophil count
eosinophilia
Allakos Investigational Site
 (4.7 away) Contact site
  • 115 views
  • 22 May, 2021
  • +68 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …

areata alopecia
Kaiser Permanente
 (9.6 away) Contact site
  • 0 views
  • 21 May, 2021
  • +69 other locations
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted …

Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +739 other locations
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well monoclonal antibodies work, either alone or in combination, against the virus that causes COVID-19. Study drug(s) will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much …

Infect Disease Doctors Med Grp
 (4.7 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +153 other locations
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein …

Kaiser Permanente-Oakland
 (9.6 away) Contact site
  • 0 views
  • 29 May, 2021
  • +106 other locations
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes

This study compares three doses of once daily semaglutide tablets in people with type 2 diabetes who were previously treated with other oral anti-diabetic medicines. Participants will be initiated on the lowest starting dose of 3 mg and gradually increased until they reach the final trial dose of 14 mg, …

Novo Nordisk Investigational Site
 (2.2 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +142 other locations
Study to Evaluate the Safety Tolerability and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age

This is a Phase 1/2/3 study in healthy children <12 years of age. Dependent upon safety and/or immunogenicity data generated during the course of this study, and the resulting assessment of benefit-risk, the safety, tolerability, and immunogenicity of BNT162b2 in participants <6 months of age may subsequently be evaluated.

Kaiser Permanente Oakland
 (9.2 away) Contact site
  • 0 views
  • 07 Jun, 2021
  • +101 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

body mass index
diabetes
overweight or obesity
Diablo Clinical Research
 (2.2 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +32 other locations
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Study of the safety and immunogenicity of 20vPnC and a booster dose of BNT162b2 administered at the same visit or each vaccine given alone

vaccination
pneumococcal conjugate
booster
pneumococcal vaccine
conjugate vaccine
Diablo Clinical Research, Inc.
 (2.2 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +26 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

invasive breast cancer
hormone therapy
pertuzumab
erbb2
HER2
Kaiser Permanente Medical Center
 (2.8 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +503 other locations